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Abstract
Background: Scale-up of malaria interventions over the last decade have yielded a significant reduction in malaria
transmission and disease burden in sub-Saharan Africa. We estimated economic gradients in the distribution of
these efforts and of their impacts within and across endemic countries.
Methods: Using Demographic and Health Surveys we computed equity metrics to characterize the distribution of
malaria interventions in 30 endemic countries proxying economic position with an asset-wealth index. Gradients were
summarized in a concentration index, tabulated against level of coverage, and compared among interventions, across
countries, and against respective trends over the period 2005–2015.
Results: There remain broad differences in coverage of malaria interventions and their distribution by wealth within
and across countries. In most, economic gradients are lacking or favor the poorest for vector control; malaria services
delivered through the formal healthcare sector are much less equitable. Scale-up of interventions in many countries
improved access across the wealth continuum; in some, these efforts consistently prioritized the poorest. Expansions
in control programs generally narrowed coverage gaps between economic strata; gradients persist in countries where
growth was slower in the poorest quintile or where baseline inequality was large. Despite progress, malaria is
consistently concentrated in the poorest, with the degree of inequality in burden far surpassing that expected
given gradients in the distribution of interventions.
Conclusions: Economic gradients in the distribution of interventions persist over time, limiting progress toward equity
in malaria control. We found that, in countries with large baseline inequality in the distribution of interventions, even a
small bias in expansion favoring the least poor yielded large gradients in intervention coverage while pro-poor growth
failed to close the gap between the poorest and least poor. We demonstrated that dimensions of disadvantage
compound for the poor; a lack of economic gradients in the distribution of malaria services does not translate to equity
in coverage nor can it be interpreted to imply equity in distribution of risk or disease burden. Our analysis testifies to the
progress made by countries in narrowing economic gradients in malaria interventions and highlights the scope for
continued monitoring of programs with respect to equity.
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Background
Over the last decade, malaria programs have been trans-
formed with increased investment, new technologies,
economic development, and shifting paradigms in global
health [1]. Prior to 2008, control efforts in the region
focused on groups at highest risk of adverse outcomes,
especially pregnant women and children under the age
of five [2]. Control programs prioritized distribution
channels most likely to reach these populations such as
routine vaccination campaigns, antenatal clinics, and
social marketing where malaria commodities were subsi-
dized or rendered for free [3, 4]. These channels benefit-
ted most those with access to health facilities, which
tended to be the less poor urban households [5, 6]. In
2008, a global call from the UN Secretary General placed
the universal coverage of malaria interventions at the
center of control efforts [7]. The aim was reflected in
the Global Action Plan for Malaria [8, 9], launched the
same year by the Roll Back Malaria, laying out a
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blueprint for control, elimination, and eventual eradica-
tion of malaria. It states that a vision of a “malaria free
world” is brought about by “achieving and sustaining
universal access to and utilization of preventive mea-
sures; achieving universal access to case management in
the public and private sectors and in the community;
and accelerating the development of surveillance
systems” [9]. The aim broadened the scope of control
efforts in endemic countries to include all ages and led
to programs shifting from targeted distribution of
insecticide-treated nets (ITNs) to mass distribution cam-
paigns and community delivery supported by routine
services. In malaria case management, fast-acting
artemisinin-based combination therapies (ACTs) replaced
monotherapy (‘non-artemisinin’ drug formulations) as the
recommended first-line treatment for uncomplicated mal-
aria in 2004 in response to emerging parasite resistance
[10]. Initially costly and scarce, these drugs became
increasingly available through the Global Fund and the
novel financing mechanisms it enabled such as the Afford-
able Medicines Facility – malaria [11, 12]. Innovative de-
livery channels were introduced in many endemic
countries to directly tackle distributional failures; these
engaged the informal health sector and emphasized
community health workers in servicing vulnerable and
hard-to-reach populations [13]. As endemic countries
adopted and adapted to these new policies, the mal-
aria service gap between the poorest and the least
poor began to narrow [14].
Economic gradients and progress toward equity in
malaria control and curative interventions have been
documented in several broad strands of literature. A
large number of studies evaluated ITN coverage follow-
ing a mass-distribution campaign in narrow geographic
areas or within a single country showing improvement
in equity after the campaign [15–18]. Socioeconomic
status has also been included as one of covariates
explaining coverage and use of malaria interventions;
while its relative importance varied by setting and model
specification, it has generally been found to be an im-
portant predictor with both use and coverage increasing
with economic status [19–21]. Several multi-country
analyses included ITN use among children under the
age of five into a composite index for maternal and child
health to track country and regional progress toward the
Millennium Development Goals [22]; these studies
found that, although relative inequalities have generally
been narrowing, appreciable differences between the
poorest and the least poor persist. There have been a
number of evaluations that focused on a single malaria
intervention (most commonly ITNs) [23, 24]. To the
best of our knowledge, only one earlier study [5] has
assessed equity across a range of malaria interventions
in a large number of endemic African countries. The
analysis drew on survey reports from 2006 to 2008 and,
as such, was constrained to comparisons between
asset-wealth quintiles. It showed that, in 13 out of 25
countries, ITN ownership was equitable while malaria
treatment for febrile children and intermittent pre-
ventive treatment in pregnant women were predomin-
antly inequitable. There has been no comprehensive
assessment of malaria interventions with respect to
equity since.
Monitoring equity in intervention coverage takes a
new meaning today as malaria control programs
mobilize efforts toward elimination [25]. Scale-up of in-
terventions and introduction of new technologies can
enhance inequities if implemented without an explicit
focus on equity [26]. While wealth-related gradients
have been narrowing, these gains were achieved at very
low baseline coverages and with extensive donor support
[27]; sustaining these gains and scaling-up toward
populations at highest risk of malaria might be a chal-
lenge for many countries [28]. This study presents an
update on the state of inequality in malaria intervention
coverage in endemic sub-Saharan African countries
through to 2015. We follow a standard framework for
assessment of equity in health [29] and interpret the
estimates it yields with respect to their relevance to con-
trol programs.
Methods
Data sources
The Demographic and Health and Malaria Indicator
Surveys (DHS/MIS) are the primary sources of data
for this study. Comparable in scope [30], these
nationally representative household surveys collect
data on a range of health behaviors and household
characteristics by interviewing women of reproductive
age [31]. In endemic countries, the questionnaire also
covers access to, and use of, malaria interventions; in
a subset of these, measurements of malaria parasite
levels and anemia in a sample of children and
pregnant women are included [32]. In the primary
analysis, we included countries that conducted at least
one survey between 2011 and 2016; of these,
countries with repeated surveys between 2003 and
2016 were included in trend analyses. Surveys by
country are listed in Additional file 1.
In an auxiliary analysis we additionally used 2015-
modeled surfaces of malaria endemicity (mean P. falcip-
arum prevalence in children aged between two and ten
(PfPR2-10)) from the Malaria Atlas Project [33] to
characterize malaria transmission at sub-national level.
This was accomplished by mapping GPS locations of
survey clusters into malaria endemicity surfaces [30, 34];
PfPR2-10 values at the centroid coordinates of the cluster
were assigned to all households.
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To enhance graphical representation of estimates we
also merged in the 2015 country mean PfPR2-10 from the
Malaria Atlas Project and population estimates from the
World Bank [35].
Outcomes
We assessed intervention coverage with a subset of
standard monitoring and evaluation indicators adopted
in global malaria strategic documents and endorsed by
endemic countries to track progress toward control and
elimination targets [19–21]. The indicators selected for
the analysis relate most directly to malaria outcomes
(protection or cure). For instance, we focus on adequate
access to ITNs within households covering all members
and compliant malaria prophylaxis for pregnant women
during an antenatal care visit rather than the broader in-
dicators of household access to any ITN or receipt of at
least one dose of sulfadoxine-pyrimethamine during
pregnancy. These more stringent definitions will yield
lower coverages and potentially higher inequality than
estimates based on indicators defined more broadly.
We assessed six malaria intervention coverage indica-
tors (‘coverage’ is used loosely herein to cover both
access and use of interventions). To capture the reach of
national malaria control programs, we evaluated ITN
coverage as a proportion of households with at least one
ITN for every two persons. ITN use was estimated as
the proportion of population that slept under an ITN
the previous night. Coverage of insecticide residual
spraying (IRS) was expressed as a proportion of house-
holds residing in dwellings sprayed with an insecticide
within the last 12 months. This definition is broader
than the population targeted by the intervention. Unlike
other malaria interventions that are deployed nationally,
IRS is implemented only in foci of high malaria trans-
mission in a subset of countries in the region.
Constrained by the data, malaria prophylaxis was evalu-
ated only among women; we calculated the proportion
of recent mothers (live birth within last 2 years) that re-
ceived at least three doses of sulfadoxine-pyrimethamine
during antenatal care visits. The distribution of curative
interventions was estimated among children under the
age of five and conditional on fever. Despite progress,
access to ACTs (current WHO recommended first-line
treatment for uncomplicated malaria [36]) remains low,
with many antimalarial drugs other than the country
recommended first-line medication in wide circulation
[34, 37]. To allow for a broader snapshot of malaria case
management, we included two indicators, namely the
proportion of children with fever that sought care at a
formal provider (i.e., outpatient department, inpatient
department, government and private health centers), and
the proportion of children with fever that were treated
with any antimalarial medication, including both ACT
and non-ACT antimalarials. More narrow definitions of
malaria case management were also assessed, including
the proportion of children with fever that received the
first-line antimalarial according to country policy, and
are reported in Additional files; we refer to these
estimates when discussing malaria treatment.
Of health indicators, we evaluated malaria parasit-
aemia in children aged 6–59 months according to
microscopy. Given the lack of a gold standard diagnostic
test for malaria that is practical for use in national sur-
vey settings [32], we also report prevalence according to
rapid diagnostic tests (RDT). RDT parasite prevalence
estimates are generally higher and show somewhat
stronger economic gradients than those based on
microscopy.
Socioeconomic status stratifier
Distribution of malaria intervention coverage and health
indicators was evaluated against an asset-wealth index;
this stratifier reflects the relative economic standing of
households in a given country at the time of the survey
[38]. Derived from a national distribution of assets
weighted with principal component analysis and ad-
justed for place of residence the index has been shown
to perform well in identifying the most disadvantaged
groups akin to other measures of relative poverty. It has
been used extensively in health equity research in low-
income settings including for malaria [5, 22, 24, 39, 40].
Statistical analysis
We calculated absolute and relative differences in indica-
tors between households in lowest and highest wealth
quintiles. We also assessed the degree of inequality in in-
dicators across the whole distribution of asset-wealth
scores with a concentration index (CIX). The CIX is a
relative measure of inequality that indicates the extent
to which an indicator is concentrated among the disad-
vantaged or the advantaged within a particular setting. It
is defined as twice the area between the concentration
curve and the line of equality [41]. Negative values of
CIX denote a disproportionate concentration of service
or health variables among the poorest, positive values -
among the least poor. The index and the corresponding
95% confidence intervals were computed with the conin-
dex command in Stata 14 SE [42]. Changes in coverage
over time were expressed in terms of excess change [29].
This metric represents the difference in average annual
change in a given indicator between the lowest and high-
est asset-wealth quintiles. Considered along the absolute
change in population average the metric allows
categorization of the trend in outcome with respect to
equity. A negative excess change at an increasing
population average suggests the expansion is pro-poor
(higher average annual increase in the poorest quintile
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compared to the least poor), and so forth [43]. We refer
to distributions or changes in distribution that favor the
least poor as ‘inequitable’, while inequalities and changes
that favor the poor are termed ‘pro-poor’ [29].
The indicators were coded following the Household
Survey Indicators for Malaria Control [44] and replicate
DHS estimates in final country reports [45]. All reported
statistics are population weighted and account for the
complex survey design. The analysis was implemented
in Stata 14 SE [46].
Results
Overall, across countries and coverage indicators, mal-
aria programs in the region are inequitable (Table 1).
Yet, in 16 out of 30 countries, ITN ownership is distrib-
uted equally or favors the poorest; in over half of the
countries, ITN use and IRS are distributed equally or
favor the poorest; for interventions relying on the formal
health sector, such as intermittent preventive treatment
in pregnancy (IPTp) and access to formal care, provider
inequities are not evident in nearly half of the countries.
These categorizations refer to relative differences in
coverage of malaria interventions across the asset-wealth
continuum within countries and do not take into ac-
count the level of intervention. For instance, in Benin,
where household access to at least one ITN for every
two persons is disproportionately higher among the
least poor (CIX = 0.07), the poorest strata have better
access to ITNs in absolute terms than the poorest
strata in Cote d’Ivoire, where the indicator is
equitably distributed (42% and 34%, respectively)
(Additional file 2: Table SA3).
Figure 1 illustrates the strength of economic gradients
in distribution of malaria interventions qualified above,
thereby addressing the question of the existing level of
inequality, comparing this across interventions. The CIX
for access to formal care – the most consistently inequit-
able coverage indicator – is plotted against country
mean (Fig. 1a). Inequity is highest in settings with
lowest access. Most high PfPR2-10 countries (in shades
of red) are at this end of the distribution; Ghana is
one notable exception. For all other intervention
coverage indicators, we found little correlation
between level and degree of inequality (Additional file 3);
that is, higher coverage is not necessarily described by a
more equitable distribution nor is low coverage consist-
ently inequitable.
Compared to access to formal care, ITN use is distrib-
uted more equitably (most country estimates above the
equality diagonal) (Fig. 1b). High PfPR2-10 countries with
large inequities in access to formal care (positive values
of concentration index on y-axis) appear to be equitable
or pro-poor in distribution of ITN use (clustering of
points around zero and –10 values of rescaled CIX on x-
axis). In Congo, Democratic Republic of the Congo,
Togo, and Uganda, access to formal care strongly favors
the least poor, while ITN use favors the poorest. On the
opposite end of the plane are a handful of lower PfPR2-10
Table 1 Summary of distribution of malaria interventions across asset-wealth index in sub-Saharan African countries in 2015a
Intervention Pro-Poor Inequitable No difference across the asset-wealth
index distribution
Household with at least one insecticide-
treated net (ITN) for every two persons
CIV, COG, GAB, GHA, LBR,
NAM, ZWE
AGO, BDI, BEN, BFA, CMR, COM,
KEN, MLI, MOZ, MWI, NER, RWA,
TZA, ZMB
COD, GIN, MDG, NGA, SEN, SLE, TCD,
TGO, UGA
Population who slept under an ITN last
night
CIV, COG, GAB, GHA, GIN,
LBR, MDG, NAM, SLE, TGO,
UGA, ZWE
AGO, BDI, CMR, COM, KEN, MOZ,
MWI, NER, RWA, TCD, TZA
BEN, BFA, COD, MLI, NGA, SEN, ZMB
Household with insecticide residual
spraying in the past 12 months
BDI, BEN, COM, GHA, LBR,
NAM, SEN, UGA, ZWE
BFA, CIV, CMR, GAB, GIN, MOZ,
NER, SLE, TCD, ZMB
MDG, MLI, MWI, NGA, TZA
Mother received 3+ doses of sulfadoxine-
pyrimethamine during antenatal care visit
AGO, BEN, CIV, CMR, GHA, GIN,
MLI, MOZ, NER, NGA, TCD, TGO,
TZA, ZMB
BDI, COD, COG, COM, GAB, KEN,
LBR, MDG, MWI, NAM, SEN, SLE, UGA
Child (<5 years) with fever sought care
at a formal provider
AGO, BEN, BFA, CIV, CMR, COG,
GIN, KEN, LBR, MLI, MOZ, NER,
NGA, RWA, TCD, TGO, TZA, UGA,
ZWE
BDI, COD, COM, GAB, GHA, MDG, MWI,
NAM, SEN, SLE, ZMB
Child (<5 years) with fever treated
with an antimalarial
MOZ, MWI, TZA, ZMB AGO, BEN, BFA, CIV, CMR, COD,
GAB, GIN, NER, NGA, TCD
BDI, COG, COM, GHA, KEN, LBR, MDG,
MLI, NAM, RWA, SEN, SLE, TGO, UGA,
ZWE
For each country (indicated by ISO3 codes), distribution of malaria intervention coverage indicators were assessed over population ranked by asset-wealth; the
degree of inequality in distribution of interventions was summarized in concentration index (CIX). Interventions were classified as “Pro-poor” if the estimated CIX
was negative, “Inequitable” if was CIX is positive, and as “No difference across the asset-wealth index distribution” if CIX was equal to zero or lacked
statistical significance
aData drawn from a subset of countries with Demographic and Health Survey/Malaria Indicator Survey conducted after 2010 (ISO3 codes and years of data
collection are detailed in Additional file 1: Table SA1)
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countries, including Burundi and Malawi, where inequal-
ity in ITN use exceeds that in access to formal care.
Anti-malarial treatment is equitable or slightly pro-
poor in low PfPR2-10 countries (shown in shades of blue)
(Fig. 1c). In high PfPR2-10 countries, antimalarial treat-
ment favors the least poor, though the degree of inequal-
ity is lower than that estimated for formal care. There
are a few exceptions to this general trend. In Democratic
Republic of the Congo and Nigeria, both medium PfPR2-
10 countries, the distribution of antimalarial treatment is
more inequitable than that of formal care. In Togo, a
high PfPR2-10 country, antimalarial treatment is distrib-
uted equitably despite large gradients in formal care fa-
voring the less poor. Distribution of first-line medication
is consistent with that of receipt of any antimalarial de-
scribed above (Additional file 3: Figure SA2). The two
indicators are correlated most closely in settings with
lower PfPR2-10, where first-line drugs account for a large
fraction of antimalarials dispensed. In higher PfPR2-10
countries, inequities in first-line treatment are lower
than those estimated for any antimalarial medication;
however, access to these medications is also significantly
lower. For instance, in Nigeria, about 33% of children
with fever are treated with an antimalarial, while only
about 6% receive the first-line drug; the least poor are
more than twice as likely as the poorest to receive either
of the medications (Additional file 2: Tables SA8-SA9).
ITN use is the most equitably distributed malaria
intervention coverage indicator. Figure 2 illustrates
changes in its distribution over the last decade. ITN use
expanded in all countries (positive values of annual ab-
solute change on the x-axis) between 2005 and 2015
(Fig. 2a); it increased somewhat faster between 2005 and
2010 compared to the later period. In most countries,
these expansions were pro-poor (positive values of ex-
cess change on the y-axis). Where expansions favored
the least poor (negative values of excess change on the
y-axis), the relative gains in coverage were smaller in ab-
solute terms than the excess change in settings where
growth was pro-poor (positive values of excess change
on the y-axis). It is primarily in these countries where
interventions expanded faster in the least poor strata
where we see inequities in distribution of ITN use today
(in shades of grey). Figure 2b presents a more nuanced
picture of intervention expansion path in three
countries, showing that failure to sustain a pro-poor
focus in expansion yields greater inequality in later
periods (Rwanda), that high baseline inequality in service
coverage defies pro-poor growth (Tanzania), and that, in
some countries, expansion in ITN use consistently prior-
itized the poorest strata (Ghana).
While relatively smaller, improvements in coverage oc-
curred across all interventions delivered by malaria con-
trol programs (Additional file 4). In about half of the
countries, these expansions were pro-poor or distributed
equally across asset-wealth strata for ITN ownership and
access to formal care. Changes in IPTp were mainly
driven by improvements in the least poor strata from
2005 to 2010, with somewhat more equitable growth in
the later period. Interpretation of changes in use of anti-
malarial medication with respect to program perform-
ance is confounded by changes in malaria epidemiology
and the shift toward diagnostically confirmed treatment.
Overall use of antimalarials decreased in most countries
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Fig. 1 Degree of asset-wealth inequality in distribution of malaria interventions in sub-Saharan African countries in 2015a. For each country, the
concentration index (CIX) is plotted for (a) access to formal care for fever among children under the age of five is plotted against its population
mean (proportion), (b) ITN use, and (c) receipt of antimalarial medication for children under the age of five with fever. Whiskers denote the 95%
confidence interval of the estimate. Country marker size is weighted with population size. Marker color code changing from bright blue to bright
red refers to country mean malaria prevalence based on 2015 Malaria Atlas Project estimates (corresponding values are given in Additional file 1:
Table SA1). aData drawn from a subset of countries with Demographic and Health Survey/Malaria Indicator Survey conducted after 2010 (country
list and year of data collection are detailed in Additional file 1: Table SA1).
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with a relatively lower reduction in the least poor com-
pared to the poorest strata. There is limited evidence
that the direction of change reversed toward expansion
in the poorest strata in the most recent period.
By pursuing malaria intervention coverage targets,
countries aim at a broader health and health equity
agenda. Tabulating malaria prevalence for a subset of
DHS/MIS countries that included malaria diagnosis, we
found that parasitaemia remains disproportionally
concentrated in the poorest; prevalence gradients are
substantially higher than what might have been expected
given distribution of coverage indicators (Table 2). Even
in countries where malaria interventions are equitable or
favor the poor (i.e., Ghana) differences in burden
between the poorest and least poor are large.
Discussion
Decisive strides against malaria over the last decade have
enabled significant expansion of control programs across
endemic countries [47]; in some, these efforts also achieved
equity in intervention coverage [5, 22, 24, 48, 49]. More re-
cent data analyzed here show that, not only has the number
of countries with equitable or pro-poor ITN ownership
and use increased by 2015, but also that the degree of in-
equality in countries where inequities persisted is
modest with the exception of a handful of low PfPR2-
10 settings. Large wealth-related gaps previously
shown in access to antimalarial medication [5]
narrowed, with 19 out of 30 countries reporting
equitable or pro-poor coverage. These include most
Affordable Medicines Facility – malaria pilot phase
countries, except Niger and Nigeria, where access to
antimalarial medication remains substantially inequit-
able. Important gains have also been made in deliver-
ing IPTp to poor women – in 13 out of 27 countries,
this preventive intervention is equitable. In Namibia
and Senegal, all malaria control interventions are dis-
tributed equitably; whereas in Ghana and Liberia and
in Sierra Leone, all control interventions, except for
IPTp and IRS, respectively, are distributed equally.
Where asset-wealth differences in coverage persist, the
relative performance of malaria interventions with
respect to equity both within and between countries
provides useful benchmarks. The large economic gradi-
ents in the distribution of curative interventions across
countries highlight the difficulty of delivering routine
care to the poor, but differences in relative degree of
inequality (i.e., a highly inequitable CIX of 0.27 in distri-
bution of access to formal care in Guinea compared to a
CIX of 0.02 in Democratic Republic of the Congo)
suggest that it is feasible to substantially reduce these
inequities. Benin and Mali achieve coverage and use of
ITNs at rates that are approximately 20 and 40 percent-
age points above those estimated for formal care; in
these countries, ITN use is also distributed equitably
across asset-wealth strata in contrast to large economic
gradients in curative care. The differential performance
of interventions within control programs indicates that
there is technical capacity to identify and deliver services
to the poor; what is needed is implementation insight to
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transfer efficiency of high-performing interventions to
those lagging behind [50]. Review of malaria programs
covering health systems, financing, and operational con-
texts is needed to gather and synthesize institutional ex-
pertise from within the region.
Differences in the level and distribution of malaria in-
terventions within endemic countries also impact adop-
tion, prioritization, and deployment of new malaria
tools. Our analyses suggest that, in high endemic set-
tings, interventions deployed via campaigns are likely to
be more equitably distributed than those requiring rou-
tine delivery through the formal sector. These consider-
ations are immediately relevant for countries currently
considering introduction of new malaria interventions
such as malaria vaccines [51]. The economic gradients
estimated here for access to the formal sector are repre-
sentative of the EPI coverage in endemic settings [52],
suggesting that much of the vaccine’s impact is likely to
be missed due to distributional failures unless routine
immunization is supplemented with periodic intensifica-
tion and outreach campaigns.
In many high PfPR2-10 countries, coverage of malaria
interventions remains low; how programs scale-up has
important implications for equity [24], in agreement
with a previous analysis [20] showing that, where ITN
use increased, gains were made across the asset-wealth
continuum, often with accelerated growth in the poorest
stratum. We find this conclusion also holds for other
malaria coverage indicators, indicating that expansions
in malaria programs in the region have largely circum-
vented the inverse care law [51]. Yet, despite pro-poor
growth, progress toward equitable distribution of malaria
interventions in many settings is limited by past high
levels of inequality; turning these programs around is a
challenge. For these countries, failure to sustain a focus
on equity in service delivery leads to greater inequality
in subsequent periods, while narrowing the gap between
poorest and least poor requires disproportionately faster
and sustained growth in the poorest strata.
These dynamics can partially explain systematic differ-
ences in the level and distribution of malaria coverage
indicators by PfPR2-10. Most high PfPR2-10 countries
were late to scale-up ITNs; these efforts relied heavily on
donor assistance that financed mass distribution cam-
paigns outside the formal health sector, enabling equit-
able coverage in these settings. In lower PfPR2-10
countries, ITN delivery relied more on routine channels
propagating disparities in access to formal care to ITN
coverage. Distributional failures in the formal health sec-
tor limit progress toward equity across malaria interven-
tions as programs rely on routine channels to maintain
coverage between campaign rounds (i.e., ITN, IPTp), to
strengthen access for priority groups, and to inform
planning and resource allocation decisions with data
sourced from governmental health facilities. Tackling
malaria requires a holistic view of the program; to
succeed, there should be a focus on strengthening the
health systems at large.
Evidence of economic gradients in intervention cover-
age lends itself to a clear programmatic interpretation –
the poor are left behind; but analogous interpretation of
equitable or pro-poor gradients may be misleading. First,
as dimensions of social and economic disadvantage over-
lap, analyses limited to broad comparisons between the
poorest and the least poor might average over important
gradients understating the true degree of disparity [53].
Second, it is not obvious whether gradients defined over
an asset-wealth index capture policy-relevant dimensions
of economic or social disadvantage in malaria-endemic
countries [39, 40, 54]. Finally, geographic and demo-
graphic clustering of malaria in low transmission settings
might undermine the capacity of conventional tools to
identify and monitor high-risk populations [25]. To illus-
trate, we analyzed ITN use by a number of common
equity stratifiers and an interaction of these dimensions
with the asset-wealth index for Liberia, a country with a
pro-poor or egalitarian distribution of most malaria in-
terventions (Fig. 3). Here, ITN use is equally distributed
across the economic strata at the national level (solid
and dashed pink lines); it is effectively equal to national
average when stratified by place of residence, education,
or PfPR2-10 (colored bars) (Fig. 3a). However, large gradi-
ents for Liberia emerge when either of the dimensions is
overlapped with the asset-wealth index (Fig. 3a). There
are large regional differences around the national
average and even stronger economic gradients within
these regions. While pro-poor at national level, ITN use
is concentrated among the least poor in rural settings,
areas of high PfPR2-10, and in all regions except for the
South Central region of Liberia, which includes the
country capital.
Equality across wealth quintiles in coverage, or con-
centration of interventions in the poorest, is likely to be
more effective in reducing burden than concentration of
interventions in the richer quintiles because of the asso-
ciation of malaria infection with low socioeconomic sta-
tus (Table 2) [55]. The areas and individuals at highest
risk contribute disproportionately to onward infection
[56], so targeting them is highly effective if they can be
identified [57]. However, identifying them is challenging
[58]. Economic and social dimensions have a role in this,
and thus need to be considered as important compo-
nents (alongside epidemiological and geographic data) in
new approaches in malaria mapping, in the development
of more comprehensive measures of malaria vulnerabil-
ity [59, 60], and in analytical tools to help malaria
control programs direct efforts towards vulnerable sub-
populations [61, 62].
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By eliminating disparities in proximal determinants
(access to preventive and curative interventions) of mal-
aria morbidity and mortality, control programs in
endemic countries address only a part of the causal
pathway from exposure to disease; the underlying socio-
ecological conditions could manifest through other
mechanisms further perpetuating health inequities [58].
The consideration is relevant to evaluation and perform-
ance targets for control programs. Differential tracking
of coverage indicators by malaria endemicity and/or
other context-specific dimensions of social or economic
disadvantage, as shown here, can enhance equity ana-
lyses [28, 32] by focusing most directly on populations at
risk. Expanding the scope of monitoring indicators to
also include quality dimensions could help direct efforts
toward increasing efficiency of current control tools. To
this end, the equity effectiveness framework can be
applied to disentangle the impact of various factors on
the gap in the effectiveness of interventions across socio-
economic gradients [52]. For instance, compounding of
disadvantage along the service delivery path has been
shown for malaria case management, where the poor are
not only less likely to seek care but also less likely to do
so in the formal sector, or to receive appropriate diagno-
sis and treatment [32].
There are a number of limitations to consider when
interpreting our findings. Due to varying survey cycles
between countries, there is some inconsistency in
reference years for reported statistics. To the extent that
expansion in malaria services accelerated closer to 2015
or accelerated differently with respect to equity, esti-
mates based on less recent surveys understate the level
of service provision, overstate the degree of inequality in
their distribution across the wealth strata, and overstate
differences in the two statistics between countries.
Timing of campaigns (i.e., IRS or ITN distribution) with
respect to survey implementation is another variable af-
fecting the estimated level of malaria services and
comparisons thereof between countries. Finally, by de-
sign, DHS surveys are to be conducted during low trans-
mission season, while MIS is conducted at peak. Survey
implementation in the field, however, spans months
averaging over the seasonality pattern in the data
collected [30]. To the extent that in some countries the
pattern is maintained comparisons will be biased.
Conclusions
The global health and development agenda place a spe-
cial emphasis on universal health coverage [63–65]. The
Global Technical Strategy for Malaria 2016–2030, in
particular, argues for universal access to interventions
for malaria prevention, diagnosis, and treatment as a
path toward elimination [63]. For endemic countries,
given the historically low access among the poorest,
adopting this vision would require overall gains in cover-
age to be accompanied with accelerated improvements
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Fig. 3 Heterogeneity in distribution of malaria interventions over transmission and alternate socioeconomic stratifiers in Liberia in 2015a:
proportion of population who slept under an ITN the previous night. a Mean and 95% confidence interval for the proportion of population who slept
under an ITN the previous night within each dimension: place of residence (urban or rural), region ((North Western, South Central, South Eastern A,
South Eastern B, North Central), mother’s highest educational level (no education, primary, secondary, higher), PfPR2-10 level (<0.1%, 0.1–5%, 5–40%, >
40%). The national average and the corresponding confidence interval are shown in solid and dash pink lines respectively. b The degree of inequality,
summarized here in a concentration index and 95% confidence interval, in distribution of ITN use with respect to asset-wealth index within each
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in disadvantaged populations. Our analysis testifies to
the progress made by countries in the region in narrow-
ing economic gradients in malaria intervention coverage
and highlights the scope for continued monitoring of
these programs with respect to equity.
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